Sunesis Pharmaceuticals to Present at the Wells Fargo Healthcare Conference
August 28 2019 - 7:00AM
Sunesis Pharmaceuticals, Inc. (Nasdaq: SNSS) today announced that
Willie Quinn, Chief Financial Officer and Senior Vice President of
Finance and Corporate Development, will present at the Wells Fargo
Healthcare Conference on Wednesday, September 4, 2019 at 10:50 AM
Eastern Time in Boston.
A live webcast of the presentation will be
available on the Sunesis website at http://ir.sunesis.com. A
replay will be archived on the "Calendar of Events" page in the
Investors and Media section of the Sunesis website for two
weeks.
About Sunesis
Pharmaceuticals
Sunesis is a biopharmaceutical company
developing novel targeted inhibitors for the treatment of
hematologic and solid cancers. Sunesis has built an experienced
drug development organization committed to improving the lives of
people with cancer. The Company is focused on advancing its novel
kinase inhibitor pipeline, with an emphasis on its oral
non-covalent BTK inhibitor vecabrutinib. Vecabrutinib is currently
being evaluated in a Phase 1b/2 study in adults with chronic
lymphocytic leukemia and other B-cell malignancies that have
progressed after prior therapies.
For additional information on Sunesis, please
visit www.sunesis.com.
SUNESIS and the logos are trademarks
of Sunesis Pharmaceuticals, Inc.
Investor and Media Inquiries:Maeve ConneightonArgot
Partners212-600-1902 |
Willie QuinnSunesis Pharmaceuticals Inc.650-266-3716 |
Sunesis Pharmaceuticals (NASDAQ:SNSS)
Historical Stock Chart
From Aug 2024 to Sep 2024
Sunesis Pharmaceuticals (NASDAQ:SNSS)
Historical Stock Chart
From Sep 2023 to Sep 2024